CGTLimited DatastaleAllorunning TherapeuticsPhase 1
BCMA/CD19-targeted allogeneic CAR-T (BCMA/CD19-targeted allogeneic CAR-T)
Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT; Newly Diagnose… · CD19
#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting